The Glasgow Prognostic Score as a Predictor of Survival after Chemoradiotherapy for Limited-Disease Small Cell Lung Cancer
This preliminary examination revealed that the GPS was significantly associated with PFS and OS in patients undergoing chemoradiotherapy for LD-SCLC, indicating its potential utility in assessing the therapeutic outcomes in LD-SCLC.
Authors
- Hiroshi Kagamu (ORCID: https://orcid.org/0000-0003-4523-8517)
- Ayako Shiono (ORCID: https://orcid.org/0000-0001-6546-3864)
- Takanori Abe (ORCID: https://orcid.org/0000-0001-6209-9446)
- Kunihiko Kobayashi (ORCID: https://orcid.org/0000-0002-6468-9068)
- Kyoichi Kaira (ORCID: https://orcid.org/0000-0001-5548-7686)
- Hisao Imai (ORCID: https://orcid.org/0000-0003-3097-4255)
- Koichi Minato
- Kosuke Hashimoto (ORCID: https://orcid.org/0000-0003-3031-0635)
- Shingo Kato (ORCID: https://orcid.org/0000-0002-6699-9334)
- Shohei Okazaki (ORCID: https://orcid.org/0000-0001-6984-8454)
- Satoshi Endo (ORCID: https://orcid.org/0000-0002-8477-5553)
- Atsuto Mouri (ORCID: https://orcid.org/0000-0001-8704-8151)
- Yu Miura (ORCID: https://orcid.org/0000-0002-2752-5873)
- Takeshi Masubuchi
- Ken Masubuchi (ORCID: https://orcid.org/0000-0001-7440-441X)
Institutions
- Hyogo Prefectural Cancer Center (JP)
- Saitama Medical University (JP)
Publication Details
- Journal
- Oncology
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1159/000540651
- Citations
- 1
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.28